Insiders who have reported open-market trades at the same companies as Corleen M. Roche. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
Ryan D. Maynard - $503K in IOVA purchases and sales on record
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Corleen M. Roche is a corporate insider, tracked as Chief Financial Officer of IOVANCE BIOTHERAPEUTICS, INC. (IOVA). InsiderAlpha holds 4 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Corleen M. Roche submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
Corleen M. Roche is Chief Financial Officer of IOVANCE BIOTHERAPEUTICS, INC. (IOVA). 4 SEC Form 4 filings on record going back to 2024, most recently on 10 August 2026.
Recent transactions
2
The latest 2 SEC Form 4 transactions reported by Corleen M. Roche.
InsiderAlpha's records for Corleen M. Roche go back to 2024: 4 primary Form 4 filings, an average of 1.3 per year. No recorded transaction carries a Rule 10b5-1 plan flag. An absent flag does not establish whether a transaction was pre-arranged or discretionary.
